The results of the ceRNA network and functional enrichment analysis showed that other m6A-related lncRNAs (SENCR, PSMB8-AS1, ITGB2-AS1, RP11-89N17.1, RP11-483I13.5 and LINC01547) also play critical roles during tumor progression by regulating the expression of important genes such as PTEN, VEGFA, MAPK1, IGF1, etc. These genes may provide us with new therapeutic targets for AML patients. The gene discussed is IGF1; the disease is neoplasm.